NanoString announces publication in the Journal of Clinical Oncology
NanoString announced the Journal of Clinical Oncology published an analysis of data in over 2,100 patients showing the risk-of-recurrence score generated by the PAM50-based Prosigna™ Breast Cancer Assay predicts the risk of late distant recurrence. October 21, 2014